tirzepatide cause gas Does make you tired? Why it happens and what to do Tirzepatide for Medical Weight Loss

FDA Crackdown on Compounded GLP-1s (Regulatory): On February 6, 2026, the FDA announced a formal intent to restrict the use of active pharmaceutical ingredients (APIs) for non-approved compounded GLP-1 drugs, targeting "mass-marketed" alternatives from companies like Hims & Hers as the national supply of brand-name versions stabilized

Ever since starting the medication, I have felt more energised

In this phase, the dose is 2.4 mg

These changes, though not classically classified as AEs, can have important implications for metabolic health and physical function, and their magnitude appears to vary depending on factors such as baseline nutritional status, physical activity, and adherence to dietary interventions